What is the purpose of this trial?
The purpose of this phase 2 open-label pilot study is to evaluate the efficacy, pharmacokinetics (PK), pharmacodynamics (PD), safety, and tolerability of MYK-461 in subjects with symptomatic HCM and LVOT obstruction aged 18-70 years.
Ages: 18 - 70 years
Dates: 10/07/2016 - 05/31/2017
Last Updated: 10/08/2016
Study HIC#: 2000020006